Research

The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation. Read More

Lymphedema patients saw a nearly 80 percent reduction in cellulitis episodes by using an advanced pneumatic compression device at home, according to a study in JAMA Dermatology co-authored by Vanderbilt University School of Nursing’s Sheila Ridner, Ph.D., and University of Minnesota School of Public Health Associate Professor Pinar Karaca-Mandic, Ph.D. Read More

When faced with ambiguous visual information, it is the visual processing areas of the brain that choose between the competing impressions, not the higher levels of the brain as previously thought. Read More

A majority of Guatemalans believe it is understandable, and sometimes even acceptable, for women who cheat on their husbands to be subjected to violence in return, the results of a new survey indicate. Read More

Structural and molecular details of an anti-fungal target's interaction with inhibitors suggest ways to design better treatments for fungal infections. Read More

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association. Read More

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies. Read More

Recent experiments at the world's largest atom smashers are producing liquid drops so small that they raise the question of how small a droplet can be and still remain a liquid. Read More

The U.S. federal government is preparing to launch a set of sweeping new regulations that will have a major impact on how biomedical researchers and social scientists work. It will require researchers to change how they get ethics approval, how they collect informed consent from participants, and more. Read More

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs. Read More

Mark Hatch, CEO and co-founder of TechShop, a fast-growing chain of co-working spaces where people come to build prototypes for the products they want to sell, is giving a free public lecture on the Maker Revolution. Read More

Two innovative but very different products designed by Vanderbilt University engineers are getting a financial push onto the market, thanks to National Science Foundation Accelerating Innovation Research–Technology Translation (AIR-TT) grants of about $200,000 each. Read More

Vanderbilt University has received a contract from the Centers for Medicare and Medicaid Services (CMS) for up to $28 million over four years to help more than 4,000 clinicians in the Southeast transform their clinical practices in ways that improve quality of patient care and hold down costs. Read More

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders. Read More

A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease. Read More

Declining use of prescription painkillers among preoperative patients seeking joint replacements indicates efforts by the state of Tennessee to tighten the spigot on opioids are beginning to have an impact, according to a study by Vanderbilt’s Andrew Shinar, M.D. Read More

Reduced-nicotine cigarettes were beneficial in reducing nicotine exposure and dependence, and also the number of cigarettes smoked per day, when compared with standard-nicotine cigarettes in a six-week study published in the New England Journal of Medicine. Read More

Paul Kramer explains why history is repeating itself in the battle over immigration. Kramer has written about immigration and border issues for the New Yorker and Slate, and been featured on National Public Radio. He has spent the last decade studying U.S. immigration history, and he’s working on a book about the forces that push people into leaving their home countries and immigrating, including the United States’ influence. Read More

Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders. Read More

New analysis shows that the scientific literature paints an overly rosy picture of the efficacy of psychotherapy for depression comparable to the bias previously found in reports of treatments with antidepressant drugs. Read More